Found: 14
Select item for more details and to access through your institution.
Docetaxelâifosfamide combination in patients with HER2 -non-overexpressing advanced breast cancer failing prior anthracyclines.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 5, p. 463
- By:
- Publication type:
- Article
Sequential Administration of 5-Fluorouracil (5FU)/Leucovorin (LV) Followed by Irinotecan (CPT-11) at Relapse versus CPT-11 Followed by 5-FU/LV in Advanced Colorectal Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2007, v. 53, n. 4, p. 282, doi. 10.1159/000102583
- By:
- Publication type:
- Article
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 3, p. 591, doi. 10.1007/s10549-014-3202-5
- By:
- Publication type:
- Article
Elevated Serum Leptin Levels: A Risk Factor for Non-Small-Cell Lung Cancer?
- Published in:
- Oncology, 2009, v. 76, n. 1, p. 19, doi. 10.1159/000177952
- By:
- Publication type:
- Article
Circulating Adiponectin Levels and Expression of Adiponectin Receptors in Relation to Lung Cancer: Two Case-Control Studies.
- Published in:
- Oncology, 2007, v. 73, n. 3/4, p. 261, doi. 10.1159/000127424
- By:
- Publication type:
- Article
A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086375
- By:
- Publication type:
- Article
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 108, doi. 10.1186/1479-5876-8-108
- By:
- Publication type:
- Article
A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Oncology, 2005, v. 69, n. 4, p. 333, doi. 10.1159/000089681
- By:
- Publication type:
- Article
Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer.
- Published in:
- Oncology, 2005, v. 69, n. 4, p. 348, doi. 10.1159/000089767
- By:
- Publication type:
- Article
Hypersensitivity Reactions to Carboplatin Administration Are Common but Not Always Severe: A 10-Year Experience.
- Published in:
- Oncology, 2001, v. 61, n. 2, p. 129, doi. 10.1159/000055363
- By:
- Publication type:
- Article
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 819, doi. 10.1007/s00280-014-2411-2
- By:
- Publication type:
- Article
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
- Published in:
- 2000
- By:
- Publication type:
- journal article